IN01

Biological Improvement & Genetic Volatility

Biological Improvement & Genetic Volatility measures a product's dependency on continuous genetic or biotechnological updates. High scores indicate significant "yield fragility" and risk of obsolescence without constant innovation. The primary business impact is potential product non-viability and substantial R&D investment requirements.

Structural assessment of biological innovation dependency. Measures 'Yield Fragility'—the risk that the product becomes obsolete or non-viable without constant genetic or biotechnological updates.

Innovation & Development Potential Score HS / ISIC Confirmed